For example, while MITF amplification is found in 15%–20% of human metastatic melanomas with poor prognosis, deep sequencing has detected no sign of alteration in MITF copy number in patient-derived melanoma metastases (Garraway et al., 2005; Harbst et al., 2014). Here, MITF is linked to melanoma.